국제특허분쟁연구회

13/12/2008 10:40 GMT ag-IP-news Candela Files Requests for Re-Examination of Palomar Hair Patents WAYLAND, MASS - Candela Corporation announced in a press release that it has filed two requests for re-examination with the United States Patent and Trademark Office (USPTO). One　 is for US Patent Number 5,595,568 (the 568 patent) and the second is for US Patent Number 5,735,844 (the 844 patent). Palomar Medical Technologies Inc. is the exclusive licensee of the patents, which are the subject of Palomar's patent infringement lawsuit brought against Candela on August 9, 2006 in the United States District Court for the District of Massachusetts. As Candela previously announced on November 18, 2008, the lawsuit is currently stayed. The company has specifically sought re-examination of claims 1-3, 6-8, 12-14, 17, 19, 20, 27, 28, 30, and 32 of the '844 patent, and claims 1, 3-10, 13, 14, 18-21 of the '568 patent. These claims include all of the claims Palomar has alleged that Candela infringes. The '568 and '844 patents are already being re-examined by the USPTO based on requests filed by a third party. "We remain resolute in our belief that the patents are invalid, and are hopeful that the USPTO will find the claims unpatentable and cancel them," President and CEO Gerard Puorro stated. "Now that the re-examination has been filed, and due to the stay in the lawsuit, we expect a precipitous drop in our legal expenses while we work to restore profitability to the Company," he continued. Candela Corporation manufactures and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies.